ArticleCancers2023

A Personalized Risk Model for Azacitidine Outcome in Myelodysplastic Syndrome and Other Myeloid Neoplasms Identified by Machine Learning Model Utilizing Real-World Data.

Kirsty Sharplin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.